About Olive Capital
Olive Capital is a venture capital firm located in Atherton, United States. As of Nov 2025, Olive Capital is an active investor, having invested in 11 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Seed round of Edison Scientific Overall, Olive Capital portfolio has seen 1 unicorn and 1 acquisition, namely Science and Pardes Biosciences. A lot of funds co-invest with Olive Capital, with names like Hawktail sharing a substantial percentage of its portfolio. Olive Capital has team of 3 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Olive Capital's List of Top Investments
Olive Capital has a portfolio of 11 companies, one of which is a Unicorn. Their most notable investments include Science and Maybell Quantum.Their portfolio spans across United States and China. They have invested in Enterprise Applications, Life Sciences, High Tech and 7 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Olive Capital:1. Science
Provider of online science magazine. They specialize in offering content in various topics such as science for patients,technologies and much more.
Key facts about Science
- Founded Year: 2021
- Location: Alameda (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $490M
- Employee Count: 318 as on Jul 31, 2026
- Investors: RAA Capital, Artis Ventures and 9 Others
- Latest Funding Round: Series C, Feb 26, 2026, $*****
- Highlight: Editors' Pick
Provider of a controlling system for superconducting qubits. It has developed a low-temperature storage system for qubits, as well as a series of high-density RF ribbon cables for quantum applications. It also offers an open-source software package that facilitates integration with industrial programmes and data security systems.
Key facts about Maybell Quantum
- Founded Year: 2021
- Location: Denver (United States)
- Stage: Series B
- Total Funding till date: $112M
- Employee Count: 80 as on Jul 31, 2026
- Investors: Addition, Lavrock Ventures and 8 Others
- Latest Funding Round: Series B, Sep 03, 2025, $*****
- Highlight: Editors' Pick
3. AKASA
Provider of revenue cycle automation platform for healthcare. It offers an Unified Automation solution aims to collect the appropriate amount of reimbursement, faster, at a lower cost for organizations. The system can evaluate existing workflows and identify the key steps and decision points in those workflows which can then be leveraged to perform those activities at a higher degree of accuracy.
Key facts about AKASA
- Founded Year: 2018
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $85M
- Employee Count: 240 as on Jul 31, 2026
- Investors: Founders Circle Capital, Bond Capital and 5 Others
- Latest Funding Round: Series B, Mar 23, 2021, $*****
- Highlight: Editors' Pick
Developer of therapeutics for pandemic diseases. The company's lead product candidate, PBI-0451, is an oral coronaviral protease inhibitor developed to treat and prevent SARS-CoV-2 infections.
Key facts about Pardes Biosciences
- Founded Year: 2020
- Location: Berkeley (United States)
- Stage: Acquired
- Total Funding till date: $51.6M
- Employee Count: 29 as on Dec 31, 2021
- Investors: Khosla Ventures, Frazier Healthcare Partners and 1 Other
- Latest Funding Round: Series C, Feb 03, 2021, $*****
- Highlight: Acquired
Developer of an AI platform for scientific research and development. The platform enables users to synthesize literature, analyze complex datasets, and design new molecules. It facilitates target discovery, data synthesis, and molecular optimization. The platform transforms datasets into reports with validated findings and publication-ready figures.
Key facts about Edison Scientific
- Location: New York (United States)
- Stage: Seed
- Total Funding till date: $70M
- Employee Count: 73 as on May 31, 2026
- Investors: Spark Capital, Susa Ventures and 4 Others
- Latest Funding Round: Seed, Nov 24, 2025, $*****
- Highlight: Editors' Pick
Olive Capital's Year-on-Year Investment Trends
Olive Capital has invested in 11 companies over the last 7 years, with an average of 1 new investment annually in the last 5 years. In 2025, it made 2 investments. Its most recent first time investment was in Edison Scientific.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2021 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 |
2019 | 1 | 0 | 1 |
Olive Capital's Investments by Stage
Olive Capital has made 5 investments in Seed stage with an average round size of $19.2M, 1 investment in Series A stage with an average round size of $33.3M and 1 investment in Unattributed stage with an average round size of $7M.Stage of entry | No. of Investments |
|---|---|
Seed | 5 |
Series A | 1 |
Unattributed | 1 |
Note: We have considered here, only first round of investments
Olive Capital's Investments by Sector
Olive Capital has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, High Tech, Life Sciences and Aerospace, Maritime and Defense Tech. Notably, it has invested in 11 Tech companies, 7 Enterprise (B2B) companies, 6 Software companies and at least 4 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 5 |
HealthTech | 2 |
High Tech | 2 |
Life Sciences | 2 |
Aerospace, Maritime and Defense Tech | 1 |
Others | 6 |
Note: We have considered here, only first round of investments
Olive Capital's Investments by Geography
Olive Capital has made most investments in United States (7).Olive Capital's recent investments
Olive Capital has not made any investment in 2026 so far.Here are the most recent investments by Olive Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 24, 2025 | United States | Seed | 3529 | [+4] | |
Jul 24, 2025 | United States | Seed | 3723 | [+11] | |
Mar 01, 2024 | United States | Series A | 1999 | ||
Nov 07, 2023 | United States | Seed | 3575 | [+8] | |
May 10, 2023 | United States | Seed | 8336 | [+9] |
Unicorns in Olive Capital's Portfolio
Olive Capital has 1 unicorn in its portfolio - Science. The most recent unicorn in their portfolio is Science which became a unicorn in 2026.Here is a list of unicorns in Olive Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
63 | Provider of online science magazine | 2021 | Alameda | Series C | dqqd{jd |
Acquired companies in Olive Capital's Portfolio
1 company from Olive Capital's portfolio has been acquired. The most recent acquisition was Pardes Biosciences in Jul 2023 by Foresite Capital for $*****.Here are Olive Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 17, 2023 | - | - | 7898 |
Team profile of Olive Capital
Olive Capital has a team of 3 members including 1 Partner and 1 Principal located in United States. Olive Capital's team does not sit on the board of any company as of now.Co-investors of Olive Capital
Over the past 7 years, 55 investors have co-invested in Olive Capital's portfolio companies. This includes funds and angels.
- Top Co-investors of Olive Capital: 53 investors entered a company along with Olive Capital. These include investors like Hawktail (3 companies).
- Invested after Olive Capital: Addition (1 company) and Greycroft (1 company) are the investors which have invested in Olive Capital's portfolio after their investments.
Recent News related to Olive Capital
•
Edison Scientific Secures $70M to Develop Autonomous AI Scientists for Scientific ResearchSiliconAngle•Dec 19, 2025•Triatomic, Edison Scientific, Spark Capital, Spark Capital and 5 others
•
Maybell Quantum Announces $25 Million Series A Funding Led by CerberusTechCodex•Mar 04, 2024•Maybell Quantum, Cerberus Capital Management, Lavrock Ventures, Caruso Ventures and 4 others
